Franklin Resources Inc Alnylam Pharmaceuticals, Inc. Transaction History

Franklin Resources Inc

  • $343 Billion
  • Q4 2024

A detailed history of Franklin Resources Inc transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 414,139 shares of ALNY stock, worth $97.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
414,139
Previous 382,973 8.14%
Holding current value
$97.1 Million
Previous $105 Million 7.5%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$232.27 - $300.43 $7.24 Million - $9.36 Million
31,166 Added 8.14%
414,139 $97.5 Million
Q3 2024

Nov 12, 2024
BUY
$233.81 - $287.01 $21.9 Million - $26.9 Million
93,647 Added 32.37%
382,973 $105 Million
Q2 2024

Aug 14, 2024
BUY
$143.31 - $247.0 $7.42 Million - $12.8 Million
51,802 Added 21.81%
289,326 $70.3 Million
Q1 2024

May 13, 2024
BUY
$146.51 - $198.2 $12.7 Million - $17.2 Million
86,596 Added 57.38%
237,524 $35.5 Million
Q4 2023

Feb 09, 2024
BUY
$151.41 - $196.57 $95,993 - $124,625
634 Added 0.42%
150,928 $28.9 Million
Q3 2023

Nov 13, 2023
SELL
$170.77 - $211.65 $12,978 - $16,085
-76 Reduced 0.05%
150,294 $26.6 Million
Q2 2023

Aug 11, 2023
SELL
$185.01 - $212.05 $1.93 Million - $2.21 Million
-10,425 Reduced 6.48%
150,370 $28.6 Million
Q1 2023

May 12, 2023
SELL
$182.66 - $235.53 $9,133 - $11,776
-50 Reduced 0.03%
160,795 $32.2 Million
Q4 2022

Feb 10, 2023
BUY
$185.53 - $241.31 $287,571 - $374,030
1,550 Added 0.97%
160,845 $38.2 Million
Q3 2022

Nov 14, 2022
BUY
$138.54 - $232.0 $441,249 - $738,920
3,185 Added 2.04%
159,295 $31.9 Million
Q2 2022

Aug 11, 2022
SELL
$120.42 - $169.29 $4.28 Million - $6.02 Million
-35,559 Reduced 18.55%
156,110 $22.8 Million
Q1 2022

May 13, 2022
SELL
$127.18 - $173.91 $2.37 Million - $3.24 Million
-18,638 Reduced 8.86%
191,669 $31.3 Million
Q4 2021

Feb 11, 2022
BUY
$159.56 - $209.29 $9.68 Million - $12.7 Million
60,652 Added 40.53%
210,307 $35.7 Million
Q3 2021

Nov 12, 2021
BUY
$169.75 - $207.73 $24.8 Million - $30.3 Million
146,050 Added 4051.32%
149,655 $28.3 Million
Q2 2021

Aug 13, 2021
BUY
$128.63 - $176.89 $66,244 - $91,098
515 Added 16.67%
3,605 $611,000
Q1 2021

May 13, 2021
SELL
$126.83 - $175.69 $62,146 - $86,088
-490 Reduced 13.69%
3,090 $436,000
Q4 2020

Feb 10, 2021
SELL
$122.97 - $147.0 $15 Million - $17.9 Million
-121,685 Reduced 97.14%
3,580 $466,000
Q3 2020

Nov 12, 2020
BUY
$121.19 - $165.49 $150,396 - $205,373
1,241 Added 1.0%
125,265 $18.2 Million
Q2 2020

Aug 13, 2020
SELL
$104.21 - $156.44 $43,142 - $64,766
-414 Reduced 0.33%
124,024 $19.6 Million
Q1 2020

May 13, 2020
SELL
$93.12 - $133.99 $195,365 - $281,111
-2,098 Reduced 1.66%
124,438 $13.5 Million
Q4 2019

Feb 12, 2020
SELL
$74.51 - $124.23 $5.41 Million - $9.02 Million
-72,646 Reduced 36.47%
126,536 $14.6 Million
Q3 2019

Nov 14, 2019
SELL
$70.9 - $87.82 $2,481 - $3,073
-35 Reduced 0.02%
199,182 $16 Million
Q2 2019

Aug 14, 2019
SELL
$65.86 - $92.79 $8,298 - $11,691
-126 Reduced 0.06%
199,217 $14.5 Million
Q1 2019

May 14, 2019
BUY
$72.76 - $93.45 $14.5 Million - $18.6 Million
199,343 New
199,343 $18.6 Million
Q3 2018

Nov 13, 2018
SELL
$87.52 - $122.67 $6.91 Million - $9.68 Million
-78,900 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
$88.31 - $107.8 $4.11 Million - $5.01 Million
-46,500 Reduced 37.08%
78,900 $7.77 Million
Q1 2018

May 10, 2018
BUY
$115.92 - $148.54 $8.69 Million - $11.1 Million
75,000 Added 148.81%
125,400 $14.9 Million
Q4 2017

Feb 14, 2018
BUY
$114.49 - $139.98 $3.51 Million - $4.29 Million
30,680 Added 155.58%
50,400 $6.4 Million
Q3 2017

Nov 13, 2017
BUY
$72.53 - $118.27 $1.43 Million - $2.33 Million
19,720
19,720 $2.32 Million

Others Institutions Holding ALNY

# of Institutions
676
Shares Held
108M
Call Options Held
839K
Put Options Held
771K
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $28.9B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email